Article
In silico, in vitro and case-control analyses as an effective combination for analyzing BRCA1 and BRCA2 unclassified variants in a population-based sample.
Cancer genetics - 1 Nov 2016
Rodríguez-Balada Marta, Roig Bàrbara, Martorell Lourdes, Melé Mireia, Salvat Mònica, Vilella Elisabet, Borràs Joan, Gumà Josep
Abstract excerpt
Ascertaining the clinical consequences of BRCA1 and BRCA2 variants of uncertain significance (VUS) is currently indispensable for providing effective genetic counseling and preventive actions for families with hereditary breast and ovarian cancer (HBOC). To this end, we conducted a combination of in silico prediction and cDNA splicing analyses of 13 BRCA1 and 10 BRCA2 VUS identified in our cohort as well as a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
